{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:11:58Z","timestamp":1787976718292,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-0520547"],"award-info":[{"award-number":["DMR-0520547"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["RICCAR17G0"],"award-info":[{"award-number":["RICCAR17G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2018-2022"],"award-info":[{"award-number":["2018-2022"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004769","name":"Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["654000"],"award-info":[{"award-number":["654000"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.nano.2019.102113","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T02:05:02Z","timestamp":1571969102000},"page":"102113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection"],"prefix":"10.1016","volume":"23","author":[{"given":"Gabriella","family":"Costabile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Azzalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola Camilla","family":"Scoffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent R.","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lepioshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Savina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Miro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Coenye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Brocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Buroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2019.102113_bb0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.nano.2019.102113_bb0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","article-title":"Treatment of lung infection in patients with cystic fibrosis: current and future strategies","volume":"11","author":"Doring","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.nano.2019.102113_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MCP.0b013e32835f1afc","article-title":"Respiratory bacterial infections in cystic fibrosis","volume":"19","author":"Ciofu","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.nano.2019.102113_bb0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1378\/chest.15-0676","article-title":"Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis","volume":"149","author":"Salsgiver","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.nano.2019.102113_bb0025","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/503485","article-title":"Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission","volume":"24","author":"Saiman","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.nano.2019.102113_bb0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1164\/rccm.200712-1834OC","article-title":"Impact of burkholderia infection on lung transplantation in cystic fibrosis","volume":"178","author":"Murray","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nano.2019.102113_bb0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCP.0000000000000431","article-title":"Lung transplantation in cystic fibrosis patients with difficult to treat lung infections","volume":"23","author":"Dupont","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.nano.2019.102113_bb0040","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nano.2019.102113_bb0045","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3389\/fmicb.2017.01592","article-title":"Burkholderia cenocepacia infections in cystic fibrosis patients: drug resistance and therapeutic approaches","volume":"8","author":"Scoffone","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nano.2019.102113_bb0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fmicb.2015.00815","article-title":"E ffl ux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia","volume":"6","author":"Scoffone","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nano.2019.102113_bb0055","doi-asserted-by":"crossref","unstructured":"Hogan AM, Scoffone VC, Makarov V, Gislason AS, Tesfu H, Stietz MS, et al. Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ. Antimicrob Agents Chemother 2018; AAC-18.","DOI":"10.1128\/AAC.01231-18"},{"key":"10.1016\/j.nano.2019.102113_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrd2510","article-title":"Cell-division inhibitors: new insights for future antibiotics","volume":"7","author":"Lock","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2019.102113_bb0065","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"10","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nano.2019.102113_bb0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2019.102113_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","article-title":"Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives","volume":"399","author":"Shegokar","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2019.102113_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007639.pub2","article-title":"Nebuliser systems for drug delivery in cystic fibrosis","author":"Daniels","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nano.2019.102113_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2014.05.008","article-title":"Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies","volume":"75","author":"d'Angelo","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2019.102113_bb0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2017.10.009","article-title":"The role of mucus on drug transport and its potential to affect therapeutic outcomes","volume":"124","author":"Murgia","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2019.102113_bb0095","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2217\/nnm.12.129","article-title":"Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy","volume":"8","author":"Forier","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2019.102113_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.12.046","article-title":"Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth","volume":"295","author":"Hoang","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102113_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2019.102113_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/wnan.165","article-title":"Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape","volume":"4","author":"Daum","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2019.102113_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700478","article-title":"Aspherical, nanostructured microparticles for targeted gene delivery to alveolar macrophages","volume":"6","author":"Mohwald","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2019.102113_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2014.06.058","article-title":"Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer","volume":"473","author":"Palma","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2019.102113_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.colsurfb.2016.01.035","article-title":"Cyclodextrin-assisted assembly of PEGylated polyester nanoparticles decorated with folate","volume":"141","author":"Conte","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2019.102113_bb0130","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1107\/S1600576718012748","article-title":"A multipurpose instrument for time-resolved ultra-small-angle and coherent X-ray scattering","volume":"51","author":"Narayanan","year":"2018","journal-title":"J Appl Cryst"},{"key":"10.1016\/j.nano.2019.102113_bb0135","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/acs.molpharmaceut.5b00098","article-title":"Toward repositioning niclosamide for antivirulence therapy of Pseudomonas aeruginosa lung infections: development of inhalable formulations through nanosuspension technology","volume":"12","author":"Costabile","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2019.102113_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolut Technol"},{"key":"10.1016\/j.nano.2019.102113_bb0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jac\/dkl231","article-title":"Portaels F. a new rapid and simple colorimetric method to detect pyrazinamide resistance in mycobacterium tuberculosis using nicotinamide","volume":"58","author":"Martin","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2019.102113_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nano.2019.102113_bb0155","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/IAI.01249-07","article-title":"Development of galleria mellonella as an alternative infection model for the Burkholderia cepacia complex","volume":"76","author":"Seed","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2019.102113_bb0160","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1021\/acs.langmuir.7b00701","article-title":"Dreiss CcA, Gonz+\u00edlez-Gaitano G. Structural and spectroscopic characterization of TPGS micelles: disruptive role of cyclodextrins and kinetic pathways","volume":"33","author":"Puig-Rigall","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.nano.2019.102113_bb0165","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1107\/S0021889810015773","article-title":"A new Guinier-Porod model","volume":"43","author":"Hammouda","year":"2010","journal-title":"J Appl Cryst"},{"key":"10.1016\/j.nano.2019.102113_bb0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-5173(02)00075-3","article-title":"Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome","volume":"238","author":"Sadzuka","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2019.102113_bb0175","series-title":"Pulmonary drug delivery: advances and challenges. Hoboken (NJ)","first-page":"87","article-title":"Formulation strategies for pulmonary delivery of poorly soluble drugs","author":"Wauthoz","year":"2015"},{"key":"10.1016\/j.nano.2019.102113_bb0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejps.2013.02.006","article-title":"The applications of vitamin E TPGS in drug delivery","volume":"49","author":"Guo","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2019.102113_bb0185","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.2147\/IJN.S34091","article-title":"New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis","volume":"7","author":"Duret","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2019.102113_bb0190","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1208\/s12248-016-0039-3","article-title":"Porous mannitol carrier for pulmonary delivery of cyclosporine a nanoparticles","volume":"19","author":"Leung","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.nano.2019.102113_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2017.10.024","article-title":"Nebulized coenzyme Q10 nanosuspensions: a versatile approach for pulmonary antioxidant therapy","volume":"113","author":"Rossi","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2019.102113_bb0200","doi-asserted-by":"crossref","first-page":"16964","DOI":"10.1021\/acsami.7b18699","article-title":"Multifunctional glycoconjugate assisted nanocrystalline drug delivery for tumor targeting and permeabilization of lysosomal-mitochondrial membrane","volume":"10","author":"Pandey","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2019.102113_bb0205","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","article-title":"Stability of nanosuspensions in drug delivery","volume":"172","author":"Wang","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102113_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.03.030","article-title":"Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery","volume":"183","author":"Pawar","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102113_bb0215","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/17425247.2016.1142524","article-title":"Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders","volume":"13","author":"Malamatari","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2019.102113_bb0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jcis.2015.05.010","article-title":"Skin transport of PEGylated poly(epsilon-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-beta-cyclodextrin","volume":"454","author":"Conte","year":"2015","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2019.102113_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijpharm.2013.05.030","article-title":"Engineering poly(ethylene oxide) buccal films with cyclodextrin: a novel role for an old excipient?","volume":"452","author":"Miro","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2019.102113_bb0230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1872211308666141028214003","article-title":"Recent survey on nanosuspension: a patent overview","volume":"9","author":"Jethara","year":"2015","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1016\/j.nano.2019.102113_bb0235","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/17425247.2015.995087","article-title":"Nebulizers for drug delivery to the lungs","volume":"12","author":"Martin","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2019.102113_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4155\/tde-2017-0102","article-title":"Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments","volume":"9","author":"Pritchard","year":"2018","journal-title":"Ther Deliv"},{"key":"10.1016\/j.nano.2019.102113_bb0245","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"30","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2019.102113_bb0250","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2016.182","article-title":"The mucus barrier to inhaled gene therapy","volume":"24","author":"Duncan","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2019.102113_bb0255","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1021\/acs.nanolett.6b03515","article-title":"Rotation-facilitated rapid transport of Nanorods in mucosal tissues","volume":"16","author":"Yu","year":"2016","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2019.102113_bb0260","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jmps.2017.12.014","article-title":"Diffusion of rod-like nanoparticles in non-adhesive and adhesive porous polymeric gels","volume":"112","author":"Wang","year":"2018","journal-title":"J Mech Phys Solids"},{"key":"10.1016\/j.nano.2019.102113_bb0265","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/mabi.201500437","article-title":"Dressings loaded with cyclodextrin-hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities","volume":"16","author":"Brackman","year":"2016","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.nano.2019.102113_bb0270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijantimicag.2012.12.009","article-title":"Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei","volume":"41","author":"Thomas","year":"2013","journal-title":"Int J Antimicrob Agents"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:10:11Z","timestamp":1761549011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419301972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":54,"alternative-id":["S1549963419301972"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2019.102113","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2019.102113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102113"}}